508 related articles for article (PubMed ID: 33073694)
1. Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection.
Rathnasinghe R; Strohmeier S; Amanat F; Gillespie VL; Krammer F; García-Sastre A; Coughlan L; Schotsaert M; Uccellini MB
Emerg Microbes Infect; 2020 Dec; 9(1):2433-2445. PubMed ID: 33073694
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection.
Rathnasinghe R; Strohmeier S; Amanat F; Gillespie VL; Krammer F; García-Sastre A; Coughlan L; Schotsaert M; Uccellini M
bioRxiv; 2020 Jul; ():. PubMed ID: 32676603
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function.
Winkler ES; Bailey AL; Kafai NM; Nair S; McCune BT; Yu J; Fox JM; Chen RE; Earnest JT; Keeler SP; Ritter JH; Kang LI; Dort S; Robichaud A; Head R; Holtzman MJ; Diamond MS
Nat Immunol; 2020 Nov; 21(11):1327-1335. PubMed ID: 32839612
[TBL] [Abstract][Full Text] [Related]
4. Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling.
Israelow B; Song E; Mao T; Lu P; Meir A; Liu F; Alfajaro MM; Wei J; Dong H; Homer RJ; Ring A; Wilen CB; Iwasaki A
J Exp Med; 2020 Dec; 217(12):. PubMed ID: 32750141
[TBL] [Abstract][Full Text] [Related]
5. Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment.
Sun J; Zhuang Z; Zheng J; Li K; Wong RL; Liu D; Huang J; He J; Zhu A; Zhao J; Li X; Xi Y; Chen R; Alshukairi AN; Chen Z; Zhang Z; Chen C; Huang X; Li F; Lai X; Chen D; Wen L; Zhuo J; Zhang Y; Wang Y; Huang S; Dai J; Shi Y; Zheng K; Leidinger MR; Chen J; Li Y; Zhong N; Meyerholz DK; McCray PB; Perlman S; Zhao J
Cell; 2020 Aug; 182(3):734-743.e5. PubMed ID: 32643603
[TBL] [Abstract][Full Text] [Related]
6. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.
Bao L; Deng W; Huang B; Gao H; Liu J; Ren L; Wei Q; Yu P; Xu Y; Qi F; Qu Y; Li F; Lv Q; Wang W; Xue J; Gong S; Liu M; Wang G; Wang S; Song Z; Zhao L; Liu P; Zhao L; Ye F; Wang H; Zhou W; Zhu N; Zhen W; Yu H; Zhang X; Guo L; Chen L; Wang C; Wang Y; Wang X; Xiao Y; Sun Q; Liu H; Zhu F; Ma C; Yan L; Yang M; Han J; Xu W; Tan W; Peng X; Jin Q; Wu G; Qin C
Nature; 2020 Jul; 583(7818):830-833. PubMed ID: 32380511
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
[TBL] [Abstract][Full Text] [Related]
8. A Mouse Model of SARS-CoV-2 Infection and Pathogenesis.
Sun SH; Chen Q; Gu HJ; Yang G; Wang YX; Huang XY; Liu SS; Zhang NN; Li XF; Xiong R; Guo Y; Deng YQ; Huang WJ; Liu Q; Liu QM; Shen YL; Zhou Y; Yang X; Zhao TY; Fan CF; Zhou YS; Qin CF; Wang YC
Cell Host Microbe; 2020 Jul; 28(1):124-133.e4. PubMed ID: 32485164
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2.
Jiang RD; Liu MQ; Chen Y; Shan C; Zhou YW; Shen XR; Li Q; Zhang L; Zhu Y; Si HR; Wang Q; Min J; Wang X; Zhang W; Li B; Zhang HJ; Baric RS; Zhou P; Yang XL; Shi ZL
Cell; 2020 Jul; 182(1):50-58.e8. PubMed ID: 32516571
[TBL] [Abstract][Full Text] [Related]
10. Mouse-Adapted SARS-CoV-2 MA10 Strain Displays Differential Pulmonary Tropism and Accelerated Viral Replication, Neurodissemination, and Pulmonary Host Responses in K18-hACE2 Mice.
Thieulent CJ; Dittmar W; Balasuriya UBR; Crossland NA; Wen X; Richt JA; Carossino M
mSphere; 2023 Feb; 8(1):e0055822. PubMed ID: 36728430
[TBL] [Abstract][Full Text] [Related]
11. Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease.
Golden JW; Cline CR; Zeng X; Garrison AR; Carey BD; Mucker EM; White LE; Shamblin JD; Brocato RL; Liu J; Babka AM; Rauch HB; Smith JM; Hollidge BS; Fitzpatrick C; Badger CV; Hooper JW
JCI Insight; 2020 Oct; 5(19):. PubMed ID: 32841215
[TBL] [Abstract][Full Text] [Related]
12. A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies.
Hassan AO; Case JB; Winkler ES; Thackray LB; Kafai NM; Bailey AL; McCune BT; Fox JM; Chen RE; Alsoussi WB; Turner JS; Schmitz AJ; Lei T; Shrihari S; Keeler SP; Fremont DH; Greco S; McCray PB; Perlman S; Holtzman MJ; Ellebedy AH; Diamond MS
Cell; 2020 Aug; 182(3):744-753.e4. PubMed ID: 32553273
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium.
Sims AC; Burkett SE; Yount B; Pickles RJ
Virus Res; 2008 Apr; 133(1):33-44. PubMed ID: 17451829
[TBL] [Abstract][Full Text] [Related]
14. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
15. Development of transgenic models susceptible and resistant to SARS-CoV-2 infection in FVB background mice.
Seo SM; Son JH; Lee JH; Kim NW; Yoo ES; Kang AR; Jang JY; On DI; Noh HA; Yun JW; Park JW; Choi KS; Lee HY; Shin JS; Seo JY; Nam KT; Lee H; Seong JK; Choi YK
PLoS One; 2022; 17(7):e0272019. PubMed ID: 35881617
[TBL] [Abstract][Full Text] [Related]
16. Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice.
Case JB; Rothlauf PW; Chen RE; Kafai NM; Fox JM; Smith BK; Shrihari S; McCune BT; Harvey IB; Keeler SP; Bloyet LM; Zhao H; Ma M; Adams LJ; Winkler ES; Holtzman MJ; Fremont DH; Whelan SPJ; Diamond MS
Cell Host Microbe; 2020 Sep; 28(3):465-474.e4. PubMed ID: 32798445
[TBL] [Abstract][Full Text] [Related]
17. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
[TBL] [Abstract][Full Text] [Related]
18. Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an
Liang Y; Li H; Li J; Yang ZN; Li JL; Zheng HW; Chen YL; Shi HJ; Guo L; Liu LD
Zool Res; 2020 Nov; 41(6):621-631. PubMed ID: 33045777
[TBL] [Abstract][Full Text] [Related]
19. The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development.
Zhang Z; Zhou L; Liu Q; Zheng Y; Tan X; Huang Z; Guo M; Wang X; Chen X; Liang S; Li W; Song K; Yan K; Li J; Li Q; Zhang Y; Yang S; Cai Z; Dai M; Xian Q; Shi ZL; Xu K; Lan K; Chen Y
Emerg Microbes Infect; 2024 Dec; 13(1):2353302. PubMed ID: 38753462
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of K18-
Moreau GB; Burgess SL; Sturek JM; Donlan AN; Petri WA; Mann BJ
Am J Trop Med Hyg; 2020 Sep; 103(3):1215-1219. PubMed ID: 32723427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]